[HTML][HTML] Radiolabelling of nanomaterials for medical imaging and therapy

J Pellico, PJ Gawne, RTM de Rosales - Chemical Society Reviews, 2021 - pubs.rsc.org
Nanomaterials offer unique physical, chemical and biological properties of interest for
medical imaging and therapy. Over the last two decades, there has been an increasing effort …

Radioactive transition metals for imaging and therapy

E Boros, AB Packard - Chemical reviews, 2018 - ACS Publications
Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

The Na+/I Symporter (NIS): Mechanism and Medical Impact

C Portulano, M Paroder-Belenitsky… - Endocrine …, 2014 - academic.oup.com
Abstract The Na+/I− symporter (NIS) is the plasma membrane glycoprotein that mediates
active I− transport in the thyroid and other tissues, such as salivary glands, stomach …

[HTML][HTML] Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives

N Lepareur, F Lacœuille, C Bouvry, F Hindré… - Frontiers in …, 2019 - frontiersin.org
Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h
physical half-life, which has been shown to be a very attractive candidate for use in …

Sodium iodide symporter: its role in nuclear medicine

JK Chung - Journal of nuclear medicine, 2002 - Soc Nuclear Med
Thyroid iodide uptake is basic to the clinical applications of radioiodine. Iodide uptake
occurs across the membrane of the thyroid follicular cells through an active transporter …

A perspective view of sodium iodide symporter research and its clinical implications

G Riesco-Eizaguirre… - European Journal of …, 2006 - academic.oup.com
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …

ICRP publication 137: occupational intakes of radionuclides: part 3

F Paquet, MR Bailey, RW Leggett… - Annals of the …, 2017 - journals.sagepub.com
The 2007 Recommendations of the International Commission on Radiological Protection
(ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a …

The sodium iodide symporter: its pathophysiological and therapeutic implications

C Spitzweg, JC Morris - Clinical endocrinology, 2002 - Wiley Online Library
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in …

Anion selectivity by the sodium iodide symporter

J Van Sande, C Massart, R Beauwens… - …, 2003 - academic.oup.com
The iodide transporter of the thyroid (NIS) has been cloned by the group of Carrasco. The
NIS-mediated transport was studied by electrophysiological methods in NIS-expressing …

Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter–expressing tissues in vivo

LS Zuckier, O Dohan, Y Li, CJ Chang… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Pertechnetate (as 99mTcO4−), 123I−, and 131I− have a long and successful history of use in
the diagnosis and therapy of thyroid cancer, with uptake into thyroid tissue mediated by the …